| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |